AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 74 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,336,000 | -87.1% | 950,000 | -86.3% | 0.44% | -88.2% |
| Q4 2020 | $95,945,000 | -26.6% | 6,937,448 | -21.8% | 3.70% | -29.3% |
| Q3 2020 | $130,713,000 | -15.3% | 8,873,953 | -6.6% | 5.23% | -19.1% |
| Q2 2020 | $154,398,000 | +9.0% | 9,501,398 | -2.7% | 6.47% | +6.8% |
| Q1 2020 | $141,674,000 | +45.1% | 9,763,920 | +102.6% | 6.06% | +73.8% |
| Q4 2019 | $97,660,000 | +2097.1% | 4,820,330 | +479.1% | 3.48% | +1973.8% |
| Q3 2019 | $4,445,000 | – | 832,370 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |